AAAAAA

   
Results: 1-9 |
Results: 9
Active efflux of the 5-HT1A receptor agonist flesinoxan via P-glycoproteinat the blood-brain barrier
Authors: van der Sandt, ICJ Smolders, R Nabulsi, L Zuideveld, KP de Boer, AG Breimer, DD
Citation: Icj. Van Der Sandt et al., Active efflux of the 5-HT1A receptor agonist flesinoxan via P-glycoproteinat the blood-brain barrier, EUR J PH SC, 14(1), 2001, pp. 81-86
P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier
Authors: van der Sandt, ICJ Gaillard, PJ Voorwinden, HH de Boer, AG Breimer, DD
Citation: Icj. Van Der Sandt et al., P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier, PHARM RES, 18(5), 2001, pp. 587-592
Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood-brain barrier
Authors: van der Sandt, ICJ Vos, CMP Nabulsi, L Blom-Roosemalen, MCM Voorwinden, HH de Boer, AG Breimer, DD
Citation: Icj. Van Der Sandt et al., Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood-brain barrier, AIDS, 15(4), 2001, pp. 483-491
Multidrug resistance P-glycoprotein hampers the access of cortisol but notof corticosterone to mouse and human brain
Authors: Karssen, AM Meijer, OC van der Sandt, ICJ Lucassen, PJ de Lange, ECM de Boer, AG de Kloet, ER
Citation: Am. Karssen et al., Multidrug resistance P-glycoprotein hampers the access of cortisol but notof corticosterone to mouse and human brain, ENDOCRINOL, 142(6), 2001, pp. 2686-2694
Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3)
Authors: Florea, BI van der Sandt, ICJ Schrier, SM Kooiman, K Deryckere, K de Boer, AG Junginger, HE Borchard, G
Citation: Bi. Florea et al., Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3), BR J PHARM, 134(7), 2001, pp. 1555-1563
In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin
Authors: de Lange, ECM Marchand, S van den Berg, DJ van der Sandt, ICJ de Boer, AG Delon, A Bouquet, S Couet, W
Citation: Ecm. De Lange et al., In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin, EUR J PH SC, 12(2), 2000, pp. 85-93
Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1 : MDR1 and Caco-2 cell lines
Authors: van der Sandt, ICJ Blom-Roosemalen, MCM de Boer, AG Breimer, DD
Citation: Icj. Van Der Sandt et al., Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1 : MDR1 and Caco-2 cell lines, EUR J PH SC, 11(3), 2000, pp. 207-214
Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier
Authors: Gaillard, PJ van der Sandt, ICJ Voorwinden, LH Vu, D Nielsen, JL de Boer, AG Breimer, DD
Citation: Pj. Gaillard et al., Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier, PHARM RES, 17(10), 2000, pp. 1198-1205
The application of microdialysis techniques to the study of drug transportacross the blood-brain barrier
Authors: de Boer, AG de Lange, ECM van der Sandt, ICJ Breimer, DD
Citation: Ag. De Boer et al., The application of microdialysis techniques to the study of drug transportacross the blood-brain barrier, BLOOD-BRAIN BARRIER AND DRUG DELIVERY TO THE CNS, 2000, pp. 77-92
Risultati: 1-9 |